Effects of Cinobufacini Injections on Proliferation and Expression of Topoisomerase of Hepatocarcinoma HepG-2 Cells
Xiaonan Cui
Abstract
Xiaonan Cui
Abstract
Objective: To study the effects of cinobufacini injections on the proliferation and expression of topoisomerase of hepatocarcinoma HepG-2 cells.Method: Experiment were divided into control group and experimental group(cinobufacini injections group 0.105,0.21,0.42 mg.L-1).Cell proliferation was assessed by Methyl Thiazolyl Tetrazolium blue reduction(MTT) assay.Apoptosis was detected by Annexin V / PI staining.Cell cycles were shown through flow cytometry method(FCM).TopoisomeraseⅠ(TopoⅠ),TopoisomeraseⅡ(Topo Ⅱ) mRNA were analyzed by Reverse transcription-polymerase chain reaction(RT-PCR).Expressions of TopoⅠ,Topo Ⅱ protein were analyzed by Western-blot.Result: Cinobufacini injection significantly inhibited HepG-2 cellproliferation(P 0.05),induced apoptosis(P 0.05) in a dose and time dependent manner,induced tumor cells arrested at the S-phase a dose dependent manner.Down regulated mRNA and protein expressions of TopoⅠ,Topo Ⅱ(P 0.05) in a dose dependent manner.Conclusion: Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation,induced apoptosis and induced tumor cells arrested at the S-phase.The down regulation of Topo Ⅰ,Topo Ⅱ expressions might be one of the anti-tumor mechanisms of cinobufacini injection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the effects of cinobufacini injections on the proliferation and expression of topoisomerase of hepatocarcinoma HepG-2 cells.Method: Experiment were divided into control group and experimental group(cinobufacini injections group 0.105,0.21,0.42 mg.L-1).Cell proliferation was assessed by Methyl Thiazolyl Tetrazolium blue reduction(MTT) assay.Apoptosis was detected by Annexin V / PI staining.Cell cycles were shown through flow cytometry method(FCM).TopoisomeraseⅠ(TopoⅠ),TopoisomeraseⅡ(Topo Ⅱ) mRNA were analyzed by Reverse transcription-polymerase chain reaction(RT-PCR).Expressions of TopoⅠ,Topo Ⅱ protein were analyzed by Western-blot.Result: Cinobufacini injection significantly inhibited HepG-2 cellproliferation(P 0.05),induced apoptosis(P 0.05) in a dose and time dependent manner,induced tumor cells arrested at the S-phase a dose dependent manner.Down regulated mRNA and protein expressions of TopoⅠ,Topo Ⅱ(P 0.05) in a dose dependent manner.Conclusion: Cinobufacini injections can inhibit human hepatocellular carcinoma HepG-2 cells proliferation,induced apoptosis and induced tumor cells arrested at the S-phase.The down regulation of Topo Ⅰ,Topo Ⅱ expressions might be one of the anti-tumor mechanisms of cinobufacini injection.
Key concepts: Apoptosis, Topoisomerase, Annexin, Flow cytometry, Molecular biology, Cell growth, Western blot, Messenger RNA